Ligand Pharmaceuticals (LGND) P/S ratio

P/S ratio today
22.2×

Ligand Pharmaceuticals (LGND) trades at 22.2× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 14.3×. That is 22.1% higher than the 11.7× of fiscal 2024. Figures as of 18 Nov 2026, 09:38 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
22.2×
P/S ratio, fiscal 2025
14.3×
Change on fiscal 2024
+22.1%
Highest on record
32.0×fiscal 2015
Lowest on record
5.7×fiscal 2022
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Ligand Pharmaceuticals P/S ratio, in more detail

Today's figure is 55.4% above the fiscal 2025 year-end.

Across the 17 fiscal year-ends on record (2009–2025), the highest was 32.0× in fiscal 2015 and the lowest 5.7× in fiscal 2022. Today's P/S ratio is higher than at 82% of the 17 fiscal year-ends on record; their median is 13.0×.

History · 17 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Ligand Pharmaceuticals P/S ratio, year by year

Ligand Pharmaceuticals (LGND) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today22.2×—$293.81—
202514.3× 22.1% up$189.07$13.21
202411.7× 21.4% up$107.15$9.14
20239.7× 68.2% up$71.42$7.40
20225.7× 16.5% down$66.80$11.63
20216.9× 7.8% up$96.36$14.01
20206.4× 62.7% down$62.04$9.72
201917.1× 31.9% up$65.06$3.80
201813.0× 43.0% down$84.65$6.52
201722.8× 17.3% up$85.42$3.75
201619.4× 39.3% down$63.39$3.26
201532.0× 81.1% up$67.64$2.11
201417.7× 20.7% down$33.19$1.88
201322.3× 69.9% up$32.81$1.47
201213.1× 68.4% up$12.94$0.99
20117.8× 4.8% up$7.40$0.95
20107.4× 17.8% up$5.56$0.75
20096.3×—$8.12$1.29

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

P/S ratio at health care companies of similar size

P/S ratio of Ligand Pharmaceuticals and comparable companies
CompanyP/S ratio
RadNet RDNT2.9×
Ligand Pharmaceuticals LGND21.9×
Teleflex TFX3.2×
Mirum Pharmaceuticals MIRM11.5×

Today's market value divided by revenue for the latest fiscal year. A company whose statements are in another currency than its shares is left out.

More on LGND

Ligand Pharmaceuticals, figure by figure

Ligand Pharmaceuticals (LGND) overview: price, valuation and scorecardAll health care companies by market value

Ligand Pharmaceuticals P/S ratio: questions and answers

What is Ligand Pharmaceuticals's P/S ratio?

Ligand Pharmaceuticals (LGND) trades at 22.2× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 14.3×. That is 22.1% higher than the 11.7× of fiscal 2024.

Is Ligand Pharmaceuticals's P/S ratio high or low compared with its own history?

Today's P/S ratio is higher than at 82% of the 17 fiscal year-ends on record; their median is 13.0×.

What are the highest and lowest P/S ratio figures on record for Ligand Pharmaceuticals?

Across the 17 fiscal year-ends on record (2009–2025), the highest was 32.0× in fiscal 2015 and the lowest 5.7× in fiscal 2022.

How is Ligand Pharmaceuticals's P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end. For Ligand Pharmaceuticals it is on record here for 17 fiscal years, 2009 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ligand Pharmaceuticals (LGND) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/LGND/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.